BCR-ABL1 tyrosine kinase inhibitor-associated thyroid dysfunction: A review of cases reported to the FDA Adverse Event Reporting System and published in the literature.
-
アブストラクト ジャーナル名 American journal of hematology 投稿日 2020/9/13 投稿者 Patel, Shital; Nayernama, Afrouz; Jones, Steven Christopher; de Claro, Romeo Angelo; Waldron, Peter E 組織名 Division of Pharmacovigilance, Office of Surveillance and Epidemiology, U.S. Food;and Drug Administration, Silver Spring, Maryland.;Division of Hematologic Malignancies I, Office of Oncologic Diseases, U.S. Food Pubmed リンク https://www.ncbi.nlm.nih.gov/pubmed/32918288/ -
お問合わせ
検索
メルマガ登録
